Title : PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions.

Pub. Date : 2016 Nov 8

PMID : 27736844






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PARP inhibitors have demonstrated durable antitumour activity in BRCA-mutated advanced OC as a single agent in the treatment and maintenance setting, particularly in platinum-sensitive disease. Platinum poly(ADP-ribose) polymerase 1 Homo sapiens